Aarti Pharma Labs (AARTIPHARM) Shareholding Pattern
NSE: AARTIPHARM • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding
43.10%
FII Holding
7.68%
DII Holding
7.66%
Public Holding
34.85%
Total Shareholders
184,489
As of
Dec 2025
View the latest shareholding pattern of Aarti Pharma Labs (AARTIPHARM) including promoter, FII, DII, and public holdings.
Track AARTIPHARM ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See
AARTIPHARM company valuation )
Aarti Pharma Labs (AARTIPHARM) Shareholding Summary
Promoters have increased holding from 42.88% to 43.10% in Dec 2025
FII/FPI have decreased holdings from 8.02% to 7.68% in Dec 2025
DIIs have increased holdings from 6.96% to 7.66% in Dec 2025
Institutional investors have increased holdings from 14.98% to 15.34% in Dec 2025
Public holding has decreased from 35.39% to 34.85% in Dec 2025
Number of shareholders decreased from 190,655 to 184,489 in Dec 2025
AARTIPHARM Quarterly Ownership Changes
Quarter-over-quarter changes for Aarti Pharma Labs from Sept 2025 to Dec 2025.
Promoter Holding Change
Sept 2025 to Dec 2025
FII Holding Change
Sept 2025 to Dec 2025
DII Holding Change
Sept 2025 to Dec 2025
Public Holding Change
Sept 2025 to Dec 2025
Aarti Pharma Labs (AARTIPHARM) Quarterly Shareholding Trends
Visual breakdown of AARTIPHARM ownership distribution over time. Learn more about AARTIPHARM ex-dividend dates .
Rising institutional holdings in AARTIPHARM often correlate with improved fundamentals. Check out AARTIPHARM complete financial .
Download complete AARTIPHARM ownership data for offline analysis. Discover AARTIPHARM true value .
All Data
Quarterly
Annual
Period
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.10%
7.68%
7.66%
0.01%
34.85%
6.70%
100.00% 184,489
Sept 2025
42.88%
8.02%
6.96%
0.01%
35.39%
6.74%
100.00% 190,655
Jun 2025
43.72%
7.35%
7.80%
0.01%
34.43%
6.69%
100.00% 187,039
Mar 2025
44.29%
7.36%
7.53%
0.01%
34.10%
6.71%
100.00% 196,314
Dec 2024
44.66%
8.64%
10.36%
0.01%
30.39%
5.94%
100.00% 185,111
Sept 2024
46.10%
7.38%
11.35%
0.01%
29.45%
5.71%
100.00% 185,436
Jun 2024
46.46%
7.06%
11.47%
0.01%
29.57%
5.43%
100.00% 189,012
Mar 2024
46.46%
8.32%
9.97%
0.01%
29.71%
5.52%
99.99% 204,122
Dec 2023
46.46%
8.16%
9.91%
0.01%
29.74%
5.72%
100.00% 215,796
Sept 2023
46.30%
0.00%
10.51%
0.01%
29.13%
14.04%
99.99% 226,286
Jun 2023
45.98%
0.00%
10.66%
0.01%
30.23%
13.12%
100.00% 258,236
Mar 2023
45.98%
0.00%
13.70%
0.01%
28.35%
11.96%
100.00% 276,664
Jan 2022
44.16%
0.00%
14.73%
0.01%
24.66%
16.44%
100.00% 305,456
AARTIPHARM promoter holding above 50% indicates strong insider confidence. Explore the AARTIPHARM quarterly performance for detailed insights.
Quarter
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.10%
7.68%
7.66%
0.01%
34.85%
6.70%
100.00% 184,489
Sept 2025
42.88%
8.02%
6.96%
0.01%
35.39%
6.74%
100.00% 190,655
Jun 2025
43.72%
7.35%
7.80%
0.01%
34.43%
6.69%
100.00% 187,039
Mar 2025
44.29%
7.36%
7.53%
0.01%
34.10%
6.71%
100.00% 196,314
Dec 2024
44.66%
8.64%
10.36%
0.01%
30.39%
5.94%
100.00% 185,111
Sept 2024
46.10%
7.38%
11.35%
0.01%
29.45%
5.71%
100.00% 185,436
Jun 2024
46.46%
7.06%
11.47%
0.01%
29.57%
5.43%
100.00% 189,012
Mar 2024
46.46%
8.32%
9.97%
0.01%
29.71%
5.52%
99.99% 204,122
Dec 2023
46.46%
8.16%
9.91%
0.01%
29.74%
5.72%
100.00% 215,796
Sept 2023
46.30%
0.00%
10.51%
0.01%
29.13%
14.04%
99.99% 226,286
Jun 2023
45.98%
0.00%
10.66%
0.01%
30.23%
13.12%
100.00% 258,236
Mar 2023
45.98%
0.00%
13.70%
0.01%
28.35%
11.96%
100.00% 276,664
Quarterly data helps track institutional investment cycles.
Year
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Dec 2025
43.10%
7.68%
7.66%
0.01%
34.85%
6.70%
100.00% 184,489
Dec 2024
44.66%
8.64%
10.36%
0.01%
30.39%
5.94%
100.00% 185,111
Dec 2023
46.46%
8.16%
9.91%
0.01%
29.74%
5.72%
100.00% 215,796
Year-over-year trends reveal long-term ownership shifts.
Understanding Aarti Pharma Labs (AARTIPHARM) Shareholding Pattern
Aarti Pharma Labs shareholding pattern reveals who owns AARTIPHARM stock and how ownership changes over time. High promoter stakes in AARTIPHARM often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AARTIPHARM trades. AARTIPHARM P/E ratio
Combine AARTIPHARM ownership analysis with price movements and financial performance for a complete investment picture. (See AARTIPHARM fair value )